Canada extends GMP to cover active pharmaceutical ingredients

05/14/2013 | In-PharmaTechnologist.com

Canada has issued new regulations, effective in November, that will establish good manufacturing practice requirements for all companies that manufacture, package/label, test or import APIs. Labeling will need to ensure that APIs can be traced from the original manufacturer to the maker of the drug in dosage form.

View Full Article in:

In-PharmaTechnologist.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC